BRIEF published on 07/31/2024 at 16:07, 2 years 1 month ago Vanguard Group Discloses Interests in International Distribution Services plc Takeover Code Securities Disclosure Vanguard Group Shareholding International Distribution Services
BRIEF published on 07/31/2024 at 16:07, 2 years 1 month ago Vanguard Group dévoile ses intérêts dans International Distribution Services plc Actionnariat Groupe D'avant-garde Code De Reprise Services De Distribution Internationale Divulgation Des Valeurs Mobilières
BRIEF published on 07/31/2024 at 16:06, 2 years 1 month ago The Vanguard Group, Inc. Discloses Position in NewRiver REIT plc Form 8.3 Disclosure Vanguard Group Shareholding NewRiver REIT
BRIEF published on 07/31/2024 at 16:06, 2 years 1 month ago The Vanguard Group, Inc. divulgue une position dans NewRiver REIT plc Actionnariat Divulgation Groupe D'avant-garde Formulaire 8.3 FPI NewRiver
BRIEF published on 07/31/2024 at 16:05, 2 years 1 month ago The Vanguard Group, Inc. Discloses Position in Virgin Money UK plc Form 8.3 Takeover Code Vanguard Group Virgin Money UK Stock Positions
BRIEF published on 07/31/2024 at 16:05, 2 years 1 month ago The Vanguard Group, Inc. divulgue sa position dans Virgin Money UK plc Groupe D'avant-garde Code De Reprise Formulaire 8.3 Virgin Money Royaume-Uni Positions En Actions
BRIEF published on 07/31/2024 at 16:05, 2 years 1 month ago GENTV.COM's "Skillhouse" Sets New Engagement and Viewership Records GENTV Skillhouse Ryan Kavanaugh Influencers Horror Film
BRIEF published on 07/31/2024 at 16:05, 2 years 1 month ago "Skillhouse" de GENTV.COM établit de nouveaux records d'engagement et d'audience GENTV Ryan Kavanaugh Maison De Compétences Influenceurs Film D'horreur
BRIEF published on 07/31/2024 at 16:05, 2 years 1 month ago Issuance of New European Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs) Crofelemer Jaguar Health European Patent CDDs Proof-of-Concept Studies
BRIEF published on 07/31/2024 at 16:05, 2 years 1 month ago La délivrance d'un nouveau brevet européen renforce la protection de la propriété intellectuelle de Jaguar Health dans le traitement des troubles diarrhéiques congénitaux (CDD) Crofelemer Santé Jaguar Brevet Européen CDD Études De Validation De Principe
Published on 09/12/2026 at 02:35, 2 hours 48 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 6 hours 23 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 7 hours 18 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 7 hours 58 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 12 hours 23 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 7 hours 8 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 7 hours 12 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 9 hours 38 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 11 hours 7 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 22 hours 23 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 22 hours 23 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 22 hours 23 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 22 hours 23 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 9 hours ago Availability of the 2026 Interim Financial Report
